僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Ianalumab （VAY-736） is a humanized, decarboxylated antibody against BAFF-R. Ianalumab can block the interaction between BAFF and BAFF-R and antagonize the apoptosis protection mediated by BAFF. Ianalumab exerts antibody-dependent cytotoxic （ADCC）, depending on effector cell activation mediated by immune receptor tyrosine activation motif （ITAM）